Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

2025 PTCE Specialty Pharmacy Day of Education in partnership with Asembia

Program Description

In the United States, over 1 million individuals are living with HIV, a chronic viral infection that requires lifelong management. These individuals also face ongoing barriers such as medication nonadherence, treatment fatigue due to pill burden, and persistent stigma contributing to health care disparities. Long-acting injectable (LAI) therapies are transforming HIV care by reducing the treatment burden and offering new opportunities to improve medication adherence for eligible patients. Despite ongoing advances in HIV management and prevention, many patients continue to face challenges in accessing health care. As the landscape of HIV treatment evolves, community pharmacists must be prepared to assess patient eligibility for LAI regimens, address adherence barriers, and promote equitable access through culturally competent communication and engagement strategies. This panel discussion will compare the efficacy and safety of LAIs with oral regimens while emphasizing practical strategies for integrating LAIs into PrEP and treatment plans to improve health care access and outcomes among diverse, socioeconomically marginalized populations.

Target audience: Community Pharmacist, Health System Pharmacist, Specialty Pharmacist

Type of activity: Application

Release date: October 28, 2025

Expiration date: October 28, 2026

Time to complete activity: 1.5 hours

Learner level: Foundational, Intermediate

Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine patient eligibility for long-acting injectable (LAI) therapy based on clinical, behavioral, and logistical factors, including adherence history and access to health care
• Compare the efficacy, safety, and administration considerations of LAI therapies with traditional oral HIV treatment and prevention regimens
• Apply culturally competent communication techniques to build trust and improve engagement with historically marginalized patient populations

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-25-350-H02-P. The activity is available for CE credit through October 28, 2026

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Christina M. Madison, PharmD, FCCP, AAHIVP, has the following financial relationships with commercial interests to disclose:
Consultant: Gilead Science, GSK, ViiV Healthcare

Speakers Bureau: Wellness Equity Alliance, Pills2Me

Kevin Kristy Aloysius, PharmD, AAHIVP, has the following relevant financial relationships with commercial interests to disclose.

Grant/Research Support: ViiV Healthcare

Consultant (advisory board: Gilead Sciences, ViiV Healthcare,

David E. Koren, PharmD, MPH, BCIDP, AAHIVP, FIDSA, has the following relevant financial relationships with commercial interests to disclose.

Speakers Bureau: Gilead Sciences, ViiV Healthcare

Consultant: Merck

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Linda M. Spooner, PharmD, BCPS, FASHP, FCCP

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Adam C. Welch, PharmD, MBA, FAPhA; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer

CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms